• NEBANNER

Factory For Sulfamethazine 57-68-1 - Hydroxypyrazolodpyrimidine pyrazolo(3,4-d)pyrimidin-1-ol – JIN DUN

Factory For Sulfamethazine 57-68-1 - Hydroxypyrazolodpyrimidine pyrazolo(3,4-d)pyrimidin-1-ol – JIN DUN

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

Our eternal pursuits are the attitude of "regard the market, regard the custom, regard the science" as well as theory of "quality the basic, have faith in the initial and administration the advanced" for Glycol Dimethacrylate, Ozonated Water Machine, 2 2 2-Trifluoroethyl Acrylate, As a leading manufacture and exporter, we appreciate a great status inside the international markets, especially in America and Europe, because of our top high-quality and sensible charges.
Factory For Sulfamethazine 57-68-1 - Hydroxypyrazolodpyrimidine pyrazolo(3,4-d)pyrimidin-1-ol – JIN DUN Detail:

It is clinically used in primary and secondary Hyperuricemia, especially in patients with hyperuricemia, as well as in patients with renal insufficiency, and in patients with recurrent or chronic gout, as well as in patients with Hyperuricemia. Used in patients with Gouty nephropathy to relieve symptoms and reduce the formation of renal uric acid stones; gout stones; used in uric acid kidney stones and uric acid kidney disease.

This product and its metabolites can inhibit xanthine oxidase, so that hypoxanthine and xanthine cannot be converted into uric acid, that is, the synthesis of uric acid is reduced, thereby reducing the concentration of uric acid in the blood and reducing the concentration of urate in the bones, Joints and kidneys, drugs that can inhibit the synthesis of uric acid. This product can inhibit the activity of liver drug enzymes.

(1) . Primary and secondary hyperuricemia, especially those with excessive uric acid production, are also used for hyperuricemia with renal insufficiency;

(2) . For the treatment of gout, suitable for recurrent or chronic gout. For patients with gouty nephropathy, it can relieve symptoms and reduce the formation of uric acid stones in the kidneys;

(3) . Tophi;

(4) . Used for uric acid kidney stones and (or) uric acid nephropathy.

Standard:usp42
Assay:98-102%

Exterior:White or almost white powder
Package : 25kg/bag

There is bone marrow suppression, which can cause pancytopenia, and the drug should be discontinued if necessary. Drink plenty of water during the medication, and make the urine neutral or alkaline to excrete diuretic acid. This product must be applied after the acute inflammation of gouty arthritis disappears (usually about two weeks after the onset). During medication, blood picture and liver and kidney function should be checked regularly.


Product detail pictures:

Factory For Sulfamethazine 57-68-1 - Hydroxypyrazolodpyrimidine pyrazolo(3,4-d)pyrimidin-1-ol – JIN DUN detail pictures


Related Product Guide:

Our pursuit and company intention is usually to "Always fulfill our purchaser requirements". We go on to acquire and layout excellent high quality products for both our previous and new consumers and realize a win-win prospect for our customers too as us for Factory For Sulfamethazine 57-68-1 - Hydroxypyrazolodpyrimidine pyrazolo(3,4-d)pyrimidin-1-ol – JIN DUN , The product will supply to all over the world, such as: Stuttgart, Congo, Libya, We taking advantage of experience workmanship, scientific administration and advanced equipment, ensure the product quality of production, we not only win the customers' faith, but also build up our brand. Today, our team is committed to innovation, and enlightenment and fusion with constant practice and outstanding wisdom and philosophy, we cater to the market demand for high-end products, to do professional products.
  • It can be said that this is a best producer we encountered in China in this industry, we feel lucky to work with so excellent manufacturer.
    5 Stars By Philipppa from Mexico - 2017.12.19 11:10
    Superb technology, perfect after-sales service and efficient work efficiency, we think this is our best choice.
    5 Stars By Federico Michael Di Marco from Burundi - 2018.11.22 12:28
    Write your message here and send it to us